These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18678855)

  • 21. Re: Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention.
    Funaki B
    J Vasc Interv Radiol; 2001 Jul; 12(7):894. PubMed ID: 11435549
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of contrast-induced nephropathy in high-risk patients with hemofiltration.
    Coca SG; Perazella MA
    Am J Med; 2007 Aug; 120(8):e9; author reply e11. PubMed ID: 17679116
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of contrast-induced nephropathy in vascular surgery patients.
    Lawlor DK; Moist L; DeRose G; Harris KA; Lovell MB; Kribs SW; Elliot J; Forbes TL
    Ann Vasc Surg; 2007 Sep; 21(5):593-7. PubMed ID: 17823041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acetylcysteine plus intravenous fluids versus intravenous fluids alone to prevent contrast-induced nephropathy in emergency computed tomography.
    Traub SJ; Mitchell AM; Jones AE; Tang A; O'Connor J; Nelson T; Kellum J; Shapiro NI
    Ann Emerg Med; 2013 Nov; 62(5):511-520.e25. PubMed ID: 23769807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
    Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
    Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Can the nephroprotective effect of N-acetylcysteine be optimized?].
    Barrios V; Escobar C; Echarri R
    Rev Esp Cardiol; 2010 Apr; 63(4):501-2. PubMed ID: 20334824
    [No Abstract]   [Full Text] [Related]  

  • 27. N-acetylcysteine and contrast-induced nephropathy.
    Wolak A; Cafri C; Zahger D
    N Engl J Med; 2006 Oct; 355(14):1498; author reply 1499-500. PubMed ID: 17024739
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy.
    Guru V; Fremes SE
    Clin Nephrol; 2004 Aug; 62(2):77-83. PubMed ID: 15356963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical practice. Preventing nephropathy induced by contrast medium.
    Barrett BJ; Parfrey PS
    N Engl J Med; 2006 Jan; 354(4):379-86. PubMed ID: 16436769
    [No Abstract]   [Full Text] [Related]  

  • 30. Preventing contrast nephropathy in catheter laboratory.
    Fung JW; Szeto CC; Yu CM
    Heart; 2007 Jun; 93(6):654-5. PubMed ID: 17502647
    [No Abstract]   [Full Text] [Related]  

  • 31. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.
    Marenzi G; Assanelli E; Marana I; Lauri G; Campodonico J; Grazi M; De Metrio M; Galli S; Fabbiocchi F; Montorsi P; Veglia F; Bartorelli AL
    N Engl J Med; 2006 Jun; 354(26):2773-82. PubMed ID: 16807414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-induced nephropathy remains a serious complication of PCI.
    Mehran R
    J Interv Cardiol; 2007 Jun; 20(3):236-40. PubMed ID: 17524117
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of N-Acetylcysteine to Prevent Contrast-Induced Nephropathy: A Meta-analysis.
    Loomba RS; Shah PH; Aggarwal S; Arora RR
    Am J Ther; 2016; 23(1):e172-83. PubMed ID: 23982694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast associated nephropathy in the elderly.
    Carrillo-Alvira F; Rivera-Bermúdez CG; Jiménez-Velázquez IZ; Ramos-Romey C; González-Concepción JJ
    Bol Asoc Med P R; 2008; 100(3):25-7. PubMed ID: 19227712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
    Subramaniam RM; Suarez-Cuervo C; Wilson RF; Turban S; Zhang A; Sherrod C; Aboagye J; Eng J; Choi MJ; Hutfless S; Bass EB
    Ann Intern Med; 2016 Mar; 164(6):406-16. PubMed ID: 26830221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-induced nephropathy and mortality: possible crucial role of asymmetric dimethylarginine.
    Andreotti F; Santucci E; Coluzzi G
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1043. PubMed ID: 18163017
    [No Abstract]   [Full Text] [Related]  

  • 37. N-acetylcysteine and contrast-induced nephropathy.
    Balderramo DC
    N Engl J Med; 2006 Oct; 355(14):1498-9; author reply 1499-500. PubMed ID: 17024740
    [No Abstract]   [Full Text] [Related]  

  • 38. Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease.
    Shavit L; Korenfeld R; Lifschitz M; Butnaru A; Slotki I
    J Interv Cardiol; 2009 Dec; 22(6):556-63. PubMed ID: 19732281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should intravenous N-acetylcysteine be considered standard of care for prevention of radio-contrast-induced nephropathy?
    Huxtable L; Raney CR; Khera GS
    J Am Coll Cardiol; 2003 Dec; 42(12):2169; author reply 2169-70. PubMed ID: 14680748
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).
    Ng TM; Shurmur SW; Silver M; Nissen LR; O'Leary EL; Rigmaiden RS; Cieciorka M; Porter LL; Ineck BA; Kline ME; Puumala SE
    Int J Cardiol; 2006 May; 109(3):322-8. PubMed ID: 16039733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.